DNA Methylation Changes in Cervical Cancers
Cervical carcinoma is one of the major causes of death in women worldwide. It is difficult to foresee a dramatic increase in cure rate even with the most optimal combination of cytotoxic drugs, surgery, and radiation; therefore, testing of molecular targeted therapies against this malignancy is highly desirable. Cervical cancer is a multistep process with accumulation of genetic and epigenetic alterations in regulatory genes, leading to activation of oncogenes and inactivation or loss of tumor suppressor genes (TSGs). In the last decade, in addition to genetic alterations, epigenetic inactivation of TSGs by promoter hypermethylation has been recognized as an important and alternative mechanism in tumorigenesis. In cervical cancer, epigenetic alterations can affect the expression of papillomavirus as well as host genes in relation to stages representing the multistep process of carcinogenesis. Here we discuss these epigenetic alterations in cervical cancer focusing on DNA methylation.
- 上一篇
Complete Open Reading Frame (C-ORF) Technique: Rapid and Efficient Method for Obtaining Complete Pro
Several approaches, generally referred to as rapid amplifica...
- 下一篇
Detection of Differentially Expressed Genes in Cancer Using Differential Display
It is estimated that the human genome contains 25,000–35,000...